Principal Investigator
Diana Lopez, MD
Brigham and Women's Hospital
Total Trials
1
As PI
1
Completed
0
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Phase 41
Trial Status
Recruiting1
Role Distribution
Principal Investigator1
PI Rate100%
Activity Timeline
Clinical Trials (1)
The Impact of Pcsk-9 Inhibition on PET CFR in Patients at High CV Risk
Stable Coronary Disease
PrincipalinvestigatorStart date: 2022-03-03
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Brigham and Women's Hospital
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
4 similar investigators found
Florence Leclercq, PU PH
University Hospital, Montpellier
5 trials
Shared therapeutic areas:
Stable Coronary Disease
Similarity Score30%
Marco Valgimigli, Dr
Azienda Ospedaliero Universitaria di Ferrara - Italy
1 trials
Shared therapeutic areas:
Stable Coronary Disease
Similarity Score30%
Xiaofei Wang, doctor
Tianjin First Central Hospital
1 trials
Shared therapeutic areas:
Stable Coronary Disease
Similarity Score30%
Alexandre Abizaid, Dr
Instituto Dante Pazzanese de Cardiologia
1 trials
Shared therapeutic areas:
Stable Coronary Disease
Similarity Score30%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
The Impact of Pcsk-9 Inhibition on PET CFR in Patients at High CV Risk
Stable Coronary Disease
All 1 trials loaded